249 related articles for article (PubMed ID: 5527170)
1. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
Randrup A
Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
[No Abstract] [Full Text] [Related]
2. The neuroleptics. 3. Pharmacology. Introduction.
Van Rossum JM; Janssen PA; Boissier JR; Julou L; Loew DM; Moller Nielsen I; Munkvad I; Randrup A; Stille G; Tedeschi DH
Mod Probl Pharmacopsychiatry; 1970; 5():23-32. PubMed ID: 5527165
[No Abstract] [Full Text] [Related]
3. Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors.
Van Rossum JM
Mod Probl Pharmacopsychiatry; 1970; 5():65-7. PubMed ID: 5527171
[No Abstract] [Full Text] [Related]
4. On the interaction between neuroleptics and antiparkinson drugs.
Julou L
Mod Probl Pharmacopsychiatry; 1970; 5():50-4. PubMed ID: 5527168
[No Abstract] [Full Text] [Related]
5. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
Arushanian EB
Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
[No Abstract] [Full Text] [Related]
6. Neurophysiological substrates of the pharmacological criteria for neuroleptics.
Stille G
Mod Probl Pharmacopsychiatry; 1970; 5():56-60. PubMed ID: 5527169
[No Abstract] [Full Text] [Related]
7. Pharmacology and physiology of stereotyped behavior.
Randrup A; Munkvad I
J Psychiatr Res; 1974; 11():1-10. PubMed ID: 4218871
[No Abstract] [Full Text] [Related]
8. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
Hornykiewicz O
Annu Rev Pharmacol Toxicol; 1977; 17():545-59. PubMed ID: 17361
[No Abstract] [Full Text] [Related]
9. [The antipsychotic action of neuroleptics and basal ganglia function].
Arushanian EB
Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
[No Abstract] [Full Text] [Related]
10. Neuroleptics and the corpus striatum: clinical implications.
Stimmel GL
Dis Nerv Syst; 1976 Apr; 37(4):219-24. PubMed ID: 1253676
[No Abstract] [Full Text] [Related]
11. Behavioral, anti-dopaminergic, and prohypnotic effects of neuroleptics during and after prolonged treatment.
Biazzi A; Fregnan GB
Adv Biochem Psychopharmacol; 1980; 24():351-7. PubMed ID: 6105785
[No Abstract] [Full Text] [Related]
12. On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats.
Fog R
Acta Neurol Scand Suppl; 1972; 50():3-66. PubMed ID: 4565013
[No Abstract] [Full Text] [Related]
13. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
[No Abstract] [Full Text] [Related]
14. Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.
Zivkovic B; Guidotti A
Brain Res; 1974 Oct; 79(3):505-9. PubMed ID: 4153770
[No Abstract] [Full Text] [Related]
15. Proceedings: Differentiation between neuroleptic antipsychotic properties and side effects by subgroups of dopaminergic neurons.
Bunney BS; Aghajanian GK
Psychopharmacol Bull; 1974 Oct; 10(4):17-8. PubMed ID: 4473793
[No Abstract] [Full Text] [Related]
16. [Farnesol and neuroleptics. II. Action of farnesol, alone or associated with a neuroleptic, on the stereotypies induced in the rat by amphetamine].
Binet P; Miocque M; Roux M; Rinjard P
Ann Pharm Fr; 1975; 33(6-7):321-8. PubMed ID: 1241259
[No Abstract] [Full Text] [Related]
17. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Khisti RT; Deshpande LS; Chopde CT
Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
[TBL] [Abstract][Full Text] [Related]
18. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
Conway PG; Uretsky NJ
J Pharmacol Exp Ther; 1982 Jun; 221(3):650-5. PubMed ID: 7201019
[No Abstract] [Full Text] [Related]
19. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
Fung YK; Uretsky NJ
J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
[TBL] [Abstract][Full Text] [Related]
20. Interaction of apomorphine, neuroleptics and stimulants with alpha-methyl-m-tyramine, a false dopaminergic transmitter.
Dorris RL; Shore PA
Biochem Pharmacol; 1974 Feb; 23(4):867-72. PubMed ID: 4150986
[No Abstract] [Full Text] [Related]
[Next] [New Search]
